TY - JOUR
T1 - Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study
AU - Heumann, Philipp
AU - Aguado-Barrera, Miguel E
AU - Avuzzi, Barbara
AU - Azria, David
AU - Briers, Erik
AU - Bultijnck, Renée
AU - Choudhury, Ananya
AU - De Ruysscher, Dirk
AU - Farcy-Jacquet, Marie-Pierre
AU - Fonteyne, Valérie
AU - Gómez Caamaño, Antonio
AU - Helmbold, Irmgard
AU - Johnson, Kerstie
AU - Kerns, Sarah L
AU - Lambrecht, Maarten
AU - Lingard, Zoe
AU - Rancati, Tiziana
AU - Rosenstein, Barry
AU - Sperk, Elena
AU - Paul Symonds, R
AU - Talbot, Christopher
AU - Valdagni, Riccardo
AU - Vega, Ana
AU - Veldeman, Liv
AU - Ward, Tim
AU - Webb, Adam
AU - West, Catharine
AU - Chang-Claude, Jenny
AU - Seibold, Petra
AU - REQUITE consortium
N1 - Funding Information:
REQUITE was funded from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement #601826. The follow-up extension of the REQUITE patients is supported by ERA-NET ERA PerMed 2018 funding (BMBF, DS-CAT, ICSIII, FRRB, ANR) and BfS funding (#3619S42261).
Funding Information:
We sincerely thank all patients that participated in the REQUITE study and all REQUITE staff involved at the following sites: Belgium: Ghent University Hospital; KU Leuven. France: ICM Montpellier, CHU Nîmes (Department of Radiation Oncology, CHU Nîmes, Nîmes, France). Germany: Zentrum für Strahlentherapie Freiburg (Dr. Petra Stegmaier); Städtisches Klinikum Karlsruhe (Dr. Bernhard Neu); ViDia Christliche Kliniken Karlsruhe (Prof. Johannes Claßen); Klinikum der Stadt Ludwigshafen GmbH (PD Dr. Thomas Schnabel); Universitätsklinikum Mannheim: Anette Kipke and Christiane Zimmermann. The researchers at DKFZ also thank Anusha Müller, Thomas Heger, Sabine Behrens, Nicholas Schreck, Axel Benner. Petra Seibold is supported by ERA PerMed 2018 funding (BMBF #01KU1912) and BfS funding (#3619S42261). Italy: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; Candiolo Cancer Institute – FPO, IRCCS. Tiziana Rancati was partially funded by Fondazione Italo Monzino. The Netherlands: Sylvie Canisius at Maastro Clinics, Maastricht. Spain: Santiago: Complexo Hospitalario Universitario de Santiago. Ana Vega is supported by Spanish Instituto de Salud Carlos III (ISCIII) funding, an initiative of the Spanish Ministry of Economy and Innovation partially supported by AvaEuropean Regional Development FEDER Funds (INT20/00071, PI19/01424, INT15/00070, INT16/00154, INT17/00133, INT20/00071, PI19/01424, PI16/00046, PI13/02030, PI10/00164), and through the Autonomous Government of Galicia (Consolidation and structuring program: IN607B); UK: University Hospitals of Leicester NHS Trust; Manchester: Jacki Routledge at Christie NHS Foundation Trust, Manchester. Catharine West, Ananya Choudhury and Zoe Lingard are supported by NIHR Manchester Biomedical Research Centre and Catharine West is supported by Cancer Research UK (C1094/A18504, C147/A25254). USA: Mount Sinai Hospital, New York.
Publisher Copyright:
© 2022 The Authors
PY - 2023/1
Y1 - 2023/1
N2 - Introduction: Previous studies showed that healthcare professionals and patients had only moderate to low agreement on their assessment of treatment-related symptoms. We aimed to determine the levels of agreement in a large cohort of prostate cancer patients. Methods: Analyses were made of data from 1,756 prostate cancer patients treated with external beam radiotherapy (RT) and/or brachytherapy in Europe and the USA and recruited into the prospective multicentre observational REQUITE study. Eleven pelvic symptoms at the end of RT were compared after translating patient-reported outcomes (PROs) into CTCAE-based healthcare professional ratings. Gwet's AC2 agreement coefficient and 95% confidence intervals were calculated for each symptom. To compare severity of grading between patients and healthcare professionals, percent agreement and deviations for each symptom were graphically depicted. Stratified and sensitivity analyses were conducted to identify potential influencing factors and to assess heterogeneity and robustness of results. Results: The agreement for the 11 pelvic symptoms varied from very good (AC2 > 0.8: haematuria, rectal bleeding, management of sphincter control) to poor agreement (AC2 ≤ 0.2: proctitis and urinary urgency). Fatigue had a negative impact on the agreement. Patients tended to grade symptoms more severely than healthcare professionals. Information on sexual dysfunction was missing more frequently in healthcare professional assessment than PROs. Conclusion: Agreement was better for observable than subjective symptoms, with patients usually grading symptoms more severely than healthcare professionals. Our findings emphasize that PROs should complement symptom assessment by healthcare professionals and be taken into consideration for clinical decision-making to incorporate the patient perspective.
AB - Introduction: Previous studies showed that healthcare professionals and patients had only moderate to low agreement on their assessment of treatment-related symptoms. We aimed to determine the levels of agreement in a large cohort of prostate cancer patients. Methods: Analyses were made of data from 1,756 prostate cancer patients treated with external beam radiotherapy (RT) and/or brachytherapy in Europe and the USA and recruited into the prospective multicentre observational REQUITE study. Eleven pelvic symptoms at the end of RT were compared after translating patient-reported outcomes (PROs) into CTCAE-based healthcare professional ratings. Gwet's AC2 agreement coefficient and 95% confidence intervals were calculated for each symptom. To compare severity of grading between patients and healthcare professionals, percent agreement and deviations for each symptom were graphically depicted. Stratified and sensitivity analyses were conducted to identify potential influencing factors and to assess heterogeneity and robustness of results. Results: The agreement for the 11 pelvic symptoms varied from very good (AC2 > 0.8: haematuria, rectal bleeding, management of sphincter control) to poor agreement (AC2 ≤ 0.2: proctitis and urinary urgency). Fatigue had a negative impact on the agreement. Patients tended to grade symptoms more severely than healthcare professionals. Information on sexual dysfunction was missing more frequently in healthcare professional assessment than PROs. Conclusion: Agreement was better for observable than subjective symptoms, with patients usually grading symptoms more severely than healthcare professionals. Our findings emphasize that PROs should complement symptom assessment by healthcare professionals and be taken into consideration for clinical decision-making to incorporate the patient perspective.
U2 - 10.1016/j.radonc.2022.11.015
DO - 10.1016/j.radonc.2022.11.015
M3 - Article
C2 - 36442608
SN - 0167-8140
VL - 178
JO - Radiotherapy and Oncology
JF - Radiotherapy and Oncology
IS - 1
M1 - 109426
ER -